Committing to vaccine R&D: a global science policy priority
- 31 December 2004
- journal article
- research article
- Published by Elsevier in Research Policy
- Vol. 33 (10) , 1657-1671
- https://doi.org/10.1016/j.respol.2004.10.003
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Use of the Social Relations Model by Group Therapists: Application and CommentaryInternational Journal of Group Psychotherapy, 2006
- Establishing a new intellectual property rights regime in the United States: Origins, content and problemsResearch Policy, 2002
- Unacceptable Costs: The Consequences of Making Knowledge Property in a Global SocietyGlobal Society, 2002
- The benefits and costs of strong patent protection: a contribution to the current debateResearch Policy, 1998
- Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug DiscoveryJournal of Industrial Economics, 1998
- Can Patents Deter Innovation? The Anticommons in Biomedical ResearchScience, 1998
- The Learning EconomyJournal of Industry Studies, 1994
- Is Science a Public Good? Fifth Mullins Lecture, Virginia Polytechnic Institute, 23 March 1993Science, Technology, & Human Values, 1994
- Returns to R&D on new drug introductions in the 1980sJournal of Health Economics, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991